News from Endo Pharmaceuticals Solutions Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 21, 2014, 12:49 ET Endo Announces Resolution of Government Investigation

Endo Pharmaceuticals, a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), announced today that it has reached a resolution of criminal and...


Oct 04, 2012, 07:00 ET Endo Health Solutions Will Detail Long-Term Strategy At 2012 Investor Day

- Highlights long-term growth drivers and investment attributes of the company - Endo updates 2012 performance, reaffirms full year...


Sep 06, 2012, 08:30 ET Endo Pharmaceuticals Announces Reformulated Version of OPANA® ER with INTAC® Technology Designed to be Crush-Resistant Accounts for more than 90 Percent of OPANA ER Total Prescription Volume

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), today announced that, according to the latest IMS data...


May 04, 2012, 10:00 ET Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference

Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the...


Mar 29, 2012, 13:30 ET Endo Announces Departure of American Medical Systems President

Endo (Nasdaq: ENDP) announced today that American Medical Systems' (AMS) Group President, Tony Bihl, will step down as head of the Endo devices...


Mar 13, 2012, 08:30 ET Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM®

 Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has filed an amendment to its Citizen Petition (CP) with the U.S. Food and Drug...


Feb 24, 2012, 07:00 ET Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance

Endo Pharmaceuticals (Nasdaq: ENDP) today reported financial results for the fourth quarter of 2011. Total revenues during the fourth quarter of...


Feb 22, 2012, 16:30 ET Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference

 Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate...


Feb 16, 2012, 08:45 ET BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals

 BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of...


Jan 09, 2012, 08:30 ET Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln, Neb.,...


Jan 06, 2012, 06:00 ET Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine

 Endo Pharmaceuticals (Nasdaq: ENDP) announced today it has signed a worldwide license and development agreement with U.S.-based...


Dec 27, 2011, 09:30 ET Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference

 Endo Pharmaceuticals (Nasdaq: ENDP) today announced that David Holveck, president and CEO will present a corporate overview at the J.P....


Dec 12, 2011, 08:00 ET Endo Announces FDA Approval of a New Formulation of Opana® ER Designed To Be Crush-Resistant

 Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has approved a new formulation of...


Nov 28, 2011, 16:05 ET Qualitest Pharmaceuticals Receives FDA Approval for Myzilra™ Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.03 mg (28 - Day TriPhasic Regimen)

Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Myzilra Tablets (Levonorgestrel and Ethinyl...


Nov 23, 2011, 08:30 ET Endo Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Leveraged Finance Conference

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer will present a corporate...


Nov 22, 2011, 08:30 ET Endo Pharmaceuticals to Present at the Piper Jaffray Annual Healthcare Conference

 Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer will present a...


Nov 14, 2011, 08:30 ET Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL

Qualitest Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Acetaminophen and Codeine Phosphate Oral Solution...


Nov 03, 2011, 08:30 ET Endo Pharmaceuticals to Present at the 2011 Credit Suisse Annual Health Care Conference

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer will present a corporate...


Nov 02, 2011, 08:30 ET Endo Pharmaceuticals Receives FDA Approval for Felodipine Extended-Release Tablets USP, 2.5mg, 5mg and 10mg

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration has approved Felodipine Extended-release Tablets...


Oct 31, 2011, 08:30 ET Endo Pharmaceuticals to Relocate From Chadds Ford, Pa., to New Facilities in Malvern

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will relocate its corporate headquarters to a new facility based in Malvern, Pa., by...


Oct 12, 2011, 10:00 ET Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011

Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter 2011 financial results on October 27, 2011 and will host a conference call and...


Sep 15, 2011, 16:05 ET Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives

Qualitest Pharmaceuticals today issued a voluntary, nationwide, retail-level recall of multiple lots of oral contraceptives. The recall is being...


Sep 13, 2011, 16:05 ET Endo Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Blaine Davis, vice president corporate affairs will present a corporate overview at the...


Sep 07, 2011, 16:05 ET Endo Pharmaceuticals to Present at the UBS Global Life Sciences Conference

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer will present a corporate...


Aug 25, 2011, 16:05 ET Endo Pharmaceuticals to Present at the Stifel Nicolaus Annual Healthcare Conference

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that Blaine Davis, vice president corporate affairs will present a corporate overview at the...